| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.88B | +7.5% |
| Cost of Revenue | $901.1M | +2.8% |
| R&D Expense | $35.3M | -4.1% |
| SG&A Expense | $408.7M | +4.3% |
| Operating Income | $1.25B | +10.8% |
| Interest Expense | $138.8M | +20.2% |
| Pre-tax Income | $1.23B | +19.6% |
| Income Tax | $277.9M | +7.4% |
| Net Income | $958.2M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $291.2M | -3.8% |
| Accounts Receivable | $434.4M | +30.0% |
| Current Assets | $911.6M | +12.5% |
| Total Assets | $4.26B | -2.3% |
| Current Liabilities | $1.24B | +60.6% |
| Long-term Debt | $3.09B | +7.2% |
| Total Liabilities | $4.16B | +2.9% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.14B | +7.9% |
| Capital Expenditures | $223.9M | -2.7% |
| Investing Cash Flow | -$124.8M | -104.5% |
| Financing Cash Flow | -$1.03B | +72.8% |
| Free Cash Flow | $920.1M | +10.8% |
| +55.9% |
| EPS (Basic) | $6.74 | +60.9% |
| EPS (Diluted) | $6.71 | +60.9% |
| Stockholders' Equity |
| $100.1M |
| -67.7% |